Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3690 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Molecular Insight starts Azedra trial

According to the company, the clinical trial is designed to determine therapeutic dosing and evaluate the safety and efficacy of Azedra, a targeted radiotherapeutic, which consists of the

Gardasil up to 100% effective, says Merck

Gardasil protects against the four strains of human papillomavirus that cause 70% of cervical cancer cases. After three years of follow up in two large phase III clinical

FDA clears Schwarz’s Parkinson’s patch

The once-daily transdermal patch Neupro will be available in the US in three strengths (2mg/24 hours; 4mg/24 hours; and 6mg/24 hours). Neupro contains rotigotine, which is designed to